Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Clinical trial NCT00835978 · COMPLETED

Trial details

NCT number: NCT00835978
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2009-08-01
Primary completion: 2012-10-01
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.